CGC
Canopy Growth CorporationNASDAQHealthcare$1.00+2.63%ClosedMarket Cap: $449.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.64
P/S
0.91
EV/EBITDA
-0.63
DCF Value
$-7.45
FCF Yield
-34.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.1%
Operating Margin
-25.5%
Net Margin
-117.3%
ROE
-52.9%
ROA
-29.5%
ROIC
-6.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $74.5M | 28.8% | $-26.4M | $-62.6M | $-0.18 | — |
| Q2 2025 | $66.7M | 32.8% | $-16.9M | $-1.6M | $-0.01 | — |
| Q1 2025 | $72.1M | 25.0% | $-22.6M | $-41.5M | $-0.22 | — |
| Q4 2024 | $65.0M | 16.2% | $-18.3M | $-220.8M | $-1.42 | — |
| FY 2024 | $269.0M | 29.6% | $-117.1M | $-598.1M | $-5.53 | — |
| Q3 2024 | $74.8M | 32.2% | $-23.8M | $-121.9M | $-1.11 | — |
| Q2 2024 | $63.0M | 34.7% | $-45.9M | $-128.3M | $-1.48 | — |
| Q1 2024 | $66.2M | 34.8% | $-29.1M | $-127.1M | $-1.60 | — |
| Q4 2023 | $72.8M | 21.3% | $-106.7M | $-92.3M | $-1.03 | — |
| FY 2023 | $297.1M | 27.2% | $-228.7M | $-657.3M | $-8.79 | — |
| Q3 2023 | $78.5M | 36.0% | $-60.3M | $-216.8M | $-2.61 | — |
| Q2 2023 | $69.6M | 33.7% | $-7.0M | $-310.0M | $-4.33 | — |